Delivery Order SPE2DB22D2006-SPE2DB25FW0EJ

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,123.07, is for the delivery of telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a completion date of February 19, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This $1,584.47 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4567301009 - Telmisartan-HCTZ 80-25 mg Tablet Unit Dose 30s, with a completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count blister packs. The $26,979.30 firm fixed-price contract has a completion date of November 22, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,649.30, is for the delivery of Telmisartan-HCTZ 40-12.5 mg Tablets in 30-count blister packs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,913.04, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 5, 2025 and a firm fixed price pricing type. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,390.87, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. It is a firm fixed-price delivery order contract with a completion date of February 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of Telmisartan-HCTZ 80-12.5 mg tablets. The $10,044.57 firm fixed price contract has an ultimate completion date of April 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,364.98, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract, valued at $15,783.19, is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,262.32, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0EJ
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets. The $28,021.22 contract has an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999.00, providing a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition. The contract allows Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/22/25, 9:59 AM